NanoVibronix, Inc.
NAOV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.13 | 0.13 | 0.22 | -0.57 |
| FCF Yield | -14.38% | -16.27% | -8.94% | -1.52% |
| EV / EBITDA | -4.58 | -5.49 | -14.06 | -19.66 |
| Quality | ||||
| ROIC | -375.44% | -81.97% | -138.43% | -83.55% |
| Gross Margin | 58.95% | 67.32% | 22.21% | 45.43% |
| Cash Conversion Ratio | 0.68 | 0.97 | 1.29 | 0.31 |
| Growth | ||||
| Revenue 3-Year CAGR | 50.39% | 10.44% | 6.47% | 47.33% |
| Free Cash Flow Growth | 30.09% | 48.81% | -61.05% | -28.79% |
| Safety | ||||
| Net Debt / EBITDA | 0.17 | 0.95 | 0.49 | 0.54 |
| Interest Coverage | -26.53 | -13.97 | -14.44 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.48 | 0.27 | 0.27 | 5.29 |
| Cash Conversion Cycle | 783.54 | 1,337.13 | 1,368.78 | 91.57 |